Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
86.70    -0.70 (-0.80%)
Bid:
86.80
Ask:
87.80
Spread: 1.00 (1.152%)
Market Cap: £364.45m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Director/PDMR Shareholding

4 Oct 2011 17:30

RNS Number : 5474P
PZ CUSSONS PLC
04 October 2011
 



4 October 2011

PZ Cussons Plc (the 'Company')

Performance Share Plan - release of shares

The Company announces that on 3 October 2011 ordinary shares of 1p each in the Company were transferred to the following Executive Directors and persons discharging managerial responsibility ('PDMRs') by the Paterson Zochonis Employee Trust ('the Trust') in relation to awards made in 2008 under the Company's Performance Share Plan ('PSP'). The shares have been held in trust for three years and, the performance conditions relating to the awards having been fully achieved, have been released in accordance with the rules of the PSP.

In addition the Executive Directors and PDMRs sold the number of shares listed below for a price of £3.3480 per share to discharge their tax obligations arising from the release of the shares.

 

Executive Director

Number of shares awarded under the PSP

Number of shares sold to discharge tax liability

Total shares released to certificate

 

Number of shares held in the Company following the award

Total beneficial interest

Mr G A Kanellis

225,750

117,390

108,360

409,340

0.09%

Mr C G Davis

141,820

73,746

68,074

258,515

0.06%

Mr B H Leigh

138,920

72,238

-

86,022

0.02%

Mr J Pantelireis

127,350

66,222

61,128

181,340

0.04%

On the same day Mr Leigh sold 66,682 ordinary shares to the Trust for a consideration of £3.3480 per share.

 

PDMR

Number of shares awarded under the PSP

Number of shares sold to discharge tax liability

Total shares released to certificate

 

Number of shares held in the Company following the award

Total beneficial interest

Ms E Birchall

45,580

23,702

-

-

0%

Mr C Gendis

44,860

23,327

21,533

28,642

0.006%

Mr S O'Hara

34,940

18,169

-

-

0%

Mr S Plant

33,280

17,306

12,987

12,987

0.003%

Mr N Simonsz

41,960

21,819

20,141

20,141

0.004%

 

 

 

Messrs Birchall and O'Hara sold their balance of shares to the Trust for a consideration of £3.3480 per share and Mr S Plant sold 2,987 shares to the Trust for a consideration of £3.3480 per share.

 

On the same day, Mr G Kostianis, who has recently been designated by the Board of the Directors of the Company as a PDMR, was awarded 42,690 shares in the Company under the PSP. Following this award, Mr Kostianis holds 92,530 shares in the Company (comprising 0.02 % of the total shares in issue).

 

The Trust is a discretionary trust under which the class of beneficiaries who may benefit comprises all bona fide employees and former employees of the Company and its subsidiaries including members of such employees' and former employees' immediate families. Accordingly, the Executive Directors and PDMRs of the Company are included in the class of beneficiaries and are deemed to have an interest in all of such shares. Subsequent to the above dealings, the Trust's holding in the ordinary shares of 1p in the Company is 238,257 shares (0.05%).

 

Name of contact and telephone number for queries:

Sam Plant

Company Secretary

PZ Cussons Plc

(T) (00) 44 (0)161 435 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMIBATMBBMBAB
Date   Source Headline
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.